WallStreetZenWallStreetZen

NYSE: RMD
Resmed Inc Stock Ownership - Who owns Resmed?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Resmed Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael J. FarrellChairman and CEO2026-01-074,991$146.34
$730.38kBuy
Peter C. FarrellDirector2026-01-072,000$248.83
$497.66kSell
Michael J. FarrellChairman and CEO2026-01-074,991$248.46
$1.24MSell
Michael J. RiderGlobal General Counsel2026-01-0250$241.75
$12.09kSell
Brett SandercockChief Financial Officer2026-01-021,000$241.75
$241.75kSell
Michael J. FarrellChairman and CEO2025-12-084,991$146.34
$730.38kBuy
Michael J. FarrellChairman and CEO2025-12-084,991$251.41
$1.25MSell
Peter C. FarrellDirector2025-12-032,000$251.47
$502.94kSell
Michael J. RiderGlobal General Counsel2025-12-0150$244.16
$12.21kSell
Brett SandercockChief Financial Officer2025-12-011,000$244.16
$244.16kSell

1 of 10

RMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RMD insiders and whales buy or sell their stock.

RMD Shareholders

What type of owners hold Resmed Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc13.04%19,040,440$4.90BInstitution
Blackrock Inc8.41%12,277,966$3.16BInstitution
State Street Corp4.49%6,549,164$1.69BInstitution
Bank Of New York Mellon Corp3.12%4,552,916$1.17BInstitution
Geode Capital Management LLC2.91%4,251,688$1.10BInstitution
Morgan Stanley1.58%2,313,138$595.82MInstitution
Invesco Ltd1.44%2,108,763$543.18MInstitution
Christopher G. Roberts1.16%1,700,337$437.97MInsider
Northern Trust Corp1.16%1,697,882$437.34MInstitution
Michael A. 1. Quinn0.88%1,277,650$329.10MInsider

1 of 3

RMD vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RMD62.63%4.27%Net SellingNet Selling
ALC48.18%0.00%
WST95.55%3.76%Net Buying
HOLX86.01%13.99%Net SellingNet Selling
BDX90.50%0.69%Net SellingNet Selling
View Top Medical Stocks

Resmed Stock Ownership FAQ

Who owns Resmed?

Resmed (NYSE: RMD) is owned by 62.63% institutional shareholders, 4.27% Resmed insiders, and 33.10% retail investors. Christopher G. Roberts is the largest individual Resmed shareholder, owning 1.70M shares representing 1.16% of the company. Christopher G. Roberts's Resmed shares are currently valued at $430.51M.

If you're new to stock investing, here's how to buy Resmed stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.